GCG and fatty liver disease: In the liver, GLP-1 RA agonists have shown significant improvement of hepatic steatosis by decreasing triglycerides [4,12] and fatty acid-induced endoplasmic reticulum (ER) stress and apoptosis, in addition to promoting autophagy of free fatty acids [11,13,14].